Relevance and importance of universal salt iodization in India

National Medical Journal of India

Volumn 10, Issue 6, 1997, Pages 290-293

  Sood, A ^a   Pandav, C S ^a   Anand, K ^a   Sankar, R ^a   Karmarkar, M G ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

IODIDE;

DIET SUPPLEMENTATION; GOITER; HUMAN; INDIA; IODINE DEFICIENCY; NEUROLOGICAL COMPLICATION; NUTRITIONAL DEFICIENCY; PRACTICE GUIDELINE; REVIEW; RISK BENEFIT ANALYSIS; THYROID CANCER; THYROID DISEASE;

DEFICIENCY DISEASES; GUIDELINES; HUMANS; INDIA; IODINE; SODIUM CHLORIDE, DIETARY;

EID: 0031418350     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Ministry of Industry. Banning sale of edible non-iodised salt - An urgent measure. Produced by the Salt Department, Ministry of Industry with support from UNICEF, 1995.
2. Sankar R, Pandav CS, Ahmed FU, Rao P, Dwivedi MP, Desai V, et al. Review of experiences with iodized oil in national programmes for control of iodine deficiency disorders. Indian J Pediatr 1995;62:381-93.
3. Choufoer JC, van Rhijn M, Querido A. Endemic goitre in Western New Guinea. II. Clinical picture, incidence and pathogenesis of endemic cretinism. J Clin Endocrinol 1965;25:385.
4. Buttfield IH, Hetzel BS. Endemic cretinism in Eastern New Guinea. Australas Ann Med 1969;18:217-21.
5. Pharoah POD, Buttfield IH, Hetzel BS. Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet 1971;1:308-10.
6. Hetzel BS. The story of iodine deficiency: An international challenge in nutrition. Delhi:Oxford University Press, 1991:36-51, 105-22.
7. Hetzel BS. The story of iodine deficiency: An international challenge in nutrition. Delhi:Oxford University Press, 1991:70-83.
8. Strait KA, Zou L, Oppenheimer JH. ß1 Isoform-specific regulation of a triiodothyronine-induced gene during cerebellar development. Mol Endocrinol 1992;6:1874-80.
9. Sood A, Schwartz HL, Oppenheimer JH. Tissue-specific regulation of malic enzyme by thyroid hormone in the neonatal rat. Biochem Biophys Res Commun 1996;222:287-91.
10. Clugston GA, Dulberg EM, Pandav CS, Tilden RL. Iodine deficiency disorders in South East Asia. In: Hetzel BS, Dunn JT, Stanbury JB (eds). The prevention and control of iodine deficiency disorders. Amsterdam:Elsevier, 1987:273-308.
11. WHO/UNICEF/ICCIDD. Indicators for assessing iodine deficiency disorders and their control through salt iodization. Report of a Joint Consultation. Geneva: WHO, 1992. WHO/NUT/94.6.
12. Dulberg EM. A model for predicting the prevalence of developmental iodine deficiency disorders from goitre data: A preliminary report. IDD Newsletter 1985;1:6.
13. Sooch SS, Deo MG, Karmarkar MG, Kochupillai N, Ramachandran K, Ramalingaswami V. Prevention of endemic goitre with iodized salt. Bull World Health Organ 1973;49:307-12.
14. Prakash R. Current status of universal salt iodization in India. Paper presented at Regional Consultation on Elimination of Iodine Deficiency Disorders in South East Asia. New Delhi:World Health Organization, Feb 1997.
15. Ramachandran M. Iodine deficiency disorders - The situation in Kerala.Proc Nutr Soc India 1990;36:70-5.
16. WHO/UNICEF/ICCIDD. Global prevalence of Iodine Deficiency Disorders. MDIS Working Paper # 1. Micronutrient Deficiency Information System. Geneva:World Health Organization, 1993.
17. Pandav CS, Kochupillai N, Karmarkar MG, Ramachandran K, Gopinath P, Nath LM. Endemic goitre in Delhi. Indian J Med Res 1980;72:81-8.
18. Sharma SK, Dham DN, Khurana KL, Jain SK, Walia RP, Maharda NS, Shukla RK. Goitre prevalence in Delhi - A baseline survey for monitoring iodated salt prophylaxis. Indian J Nucl Med 1988;2:18-21.
19. Pandav CS, Malik A, Anand K, Pandav S, Karmarkar MG. Prevalence of iodine deficiency disorders among school children of National Capital Territory of Delhi. International Council for Control of Iodine Deficiency Disorders; Regional Office for South Asia and Pacific, 1996.
20. Pandav CS, Sachdeva I, Anand K, Pandav S, Karmarkar MG. Use of iodised salt in the households of students of Government middle schools of the National Capital Territory of Delhi. International Council for the Control of Iodine Deficiency Disorders; Regional Office for South Asia & Pacific, 1996.
21. Pandav CS, Anand K. Towards elimination of iodine deficiency disorders in India. Indian J Pediatr 1995;62:545-55.
22. Manner MGV, Dunn JT. Salt iodization for the elimination of iodine deficiency. ICCIDD/MI/UNICEF/WHO, 1995:69-72.
23. Pandav CS. Identification, measurement and valuation of costs. In: Pandav CS. Yes. Worthwhile Investment in Health: Economic Evaluation of Iodine Deficiency Disorders Control Programme in Sikkim. Delhi:Oxford University Press, 1997:118.
24. Matovinovic J. Complications of goitre prophylaxis. In: Stanbury JB, Hetzel BS (eds). Endemic goitre and endemic cretinism. New York:John Wiley & Son, Inc., 1980:533-49.
25. Roti E, Vangenakis AG. Effect of excess iodide: Clinical aspects. In: Braverman LE, Utiger RD (eds). The thyroid: A fundamental and clinical text. Philadelphia:J.B. Lippincott, 1995:390-402.
26. Recommended iodine levels in salt and guidelines for monitoring their adequacy and effectiveness. WHO/NUT/96.13.
27. Stewart JC, Vidor GI, Buttfield IH, Hetzel BS. Epidemic thyrotoxicosis in Northern Tasmania: Studies of clinical features and iodine nutrition. Aust N Z J Med 1971;3:203-11.
28. Pandav CS, Mohan R, Karmarkar MG, Subramanian P, Nath LM. Iodine deficiency in India. Natl Med J India 1989;2:18-21.
29. Bourdox PP, Ermans AM, Mukalay WA, Mukalay A, Filetti S, Vigneri R, et al. Iodine-induced thyrotoxicosis in Kivu, Zaire. Lancet 1996;347:552-3.
30. Todd CH, Allain T, Gomo ZAR, Hasler JA, Ndiweni M, Oken E, et al. Increase in thyrotoxicosis associated with iodine supplements in Zimbabwe. Lancet 1995;346: 1563-4.
31. Adams DD, Kennedy TH, Stewart JC, Utiger RD, Vidor GI. Hyperthyroidism in Tasmania following iodide supplementation: Measurements of thyroid-stimulating autoantibodies and thyrotropin. J Clin Endocrinol Metab 1975;41:221-8.
32. Clugston G, Beaudry M, Delange F. Iodine-induced thyrotoxicosis. Lancet 1996;347:1051.
33. Baltisberger BL, Minder CE, Burgi H. Decrease in incidence of toxic nodular goitre in a region of Switzerland after full correction of mild iodine deficiency. Eur J Endocrinol 1995;132:546-9.
34. Laurberg P, Pedersen KM, Vestergaard H, et al. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area v. high incidence of Graves' disease in the young in a high iodine intake area: Comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Int Med 1991;229:415-20.
35. Iodine and health: A statement by WHO. 1994 WHO/NUT/94.4.
36. Nagataki S. The role of iodine in the thyroid disease. In: Programme & Abstracts. Asia & Oceania Thyroid Association, Thyroid Meeting. Seoul:Asia and Oceania Thyroid Association, 1984:38.
37. Rubery E, Smales E. Iodine prophylaxis following nuclear accidents. Proceedings of a Joint WHO/CEC Workshop. Oxford:Pergamon Press, 1988.
38. World summit for children-mid-decade goal: Iodine deficiency disorders. UNICEF-WHO Joint Committee on Health Policy. Special Session, Geneva, Jan 1994, JCHPSS/94/2.7.
39. Forty-ninth World Health Assembly Resolution on 'Prevention and control of iodine deficiency disorders' (WHA49.13) 1996, Geneva.
40. Hetzel BS, Dunn JT, Stanbury JB. The prevention and control of iodine deficiency disorders. Amsterdam, New York, Oxford:Elsevier, 1987.